Veraxa Biotech (VRXA) News
NASDAQ: VRXAHealth CareBiotechnology: Pharmaceutical PreparationsUSD
1.04+0.01 (+0.97%)
At close: Nov 20, 4:00 PM ET · Delayed 15 min
VRXA news summary
We found 2 recent headlines mentioning Veraxa Biotech (VRXA): 0 in the past week and 0 in the past 30 days, most often from Business Insider, GlobeNewswire. For price context, VRXA is up 0.97% at $1.04. The most recent story, "VERAXA Biotech (NASDAQ: VRXA) Expands Human-Relevant Testing Strategy to Advance Antibody-Based Cancer Pipeline", was published by Business Insider on Oct 21, 2026.
Headlines link to the original publishers. MetaCap does not republish third-party articles.
Summary generated from market data by MetaCap's automated system. Methodology
Latest Veraxa Biotech headlines
- VERAXA Biotech (NASDAQ: VRXA) Expands Human-Relevant Testing Strategy to Advance Antibody-Based Cancer Pipeline<img src="https://app.financewire.com/storage/uploads/images/vrxa_1792598419rxdGGzf0ew.jpg" alt="Featured Image" /><p class="sc-kGTyPW jmTMzx">Austin, Texas, October 21st, 2026,…Business Insider
- VERAXA Biotech Presents in vivo Proof-of-Concept Data for BiTAC®-ADC Technology at World ADC CongressVERAXA Biotech presents first in vivo proof-of-concept for BiTAC®-ADC: tumor-selective activation with potent anti-tumor efficacy and improved safety.GlobeNewswire